Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Lay Health Worker Engage, Educate, and Encourage Patients to Share (LEAPS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03699748
Recruitment Status : Recruiting
First Posted : October 8, 2018
Last Update Posted : October 1, 2019
Sponsor:
Collaborators:
National Institutes of Health (NIH)
National Institute on Minority Health and Health Disparities (NIMHD)
Information provided by (Responsible Party):
Manali Indravadan Patel, Stanford University

Brief Summary:
The purpose of the LEAPS program is to understand how a trained lay health worker who engages with newly diagnosed patients after a diagnosis of an advanced stage of cancer can help to engage patients in advance care planning, improve patient satisfaction with their decision-making, activation, quality of life, and healthcare resource utilization.

Condition or disease Intervention/treatment Phase
End of Life Cancer Behavioral: Lay Health Worker Intervention Other: Usual Care Not Applicable

Detailed Description:
Unite Here Health proposes to implement and evaluate several critical elements to be in alignment with the mission of the organization to provide high value care to their members. The Lay Health Worker Engages, Educates, and Encourages Patients to Share intervention is an innovative program that will strengthen provider-patient relationship and facilitate whole person care about matters important to Unite Here Health members who are diagnosed with cancer and important to support network and family. The project is intended to help establish Goals of Care Plan with appropriate documentation, develop, deploy, and evaluate a model of care for persons with cancer that is intended to improve clinical outcomes and experience of care for individuals. The intervention provides patients with lay health coaches who assist patients and their families in discussing goals of care and engage in shared-decision making. The goal of the project is to demonstrate that there is improved documentation of goals of care, patient experiences, patient activation and quality of life outcomes, and that the program helps to reduce utilization of health care resources at the end of life.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 120 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Health Services Research
Official Title: Lay Health Worker Engage, Educate, and Encourage Patients to Share
Actual Study Start Date : October 3, 2018
Estimated Primary Completion Date : October 3, 2021
Estimated Study Completion Date : October 3, 2021

Arm Intervention/treatment
Experimental: Intervention Group Arm

Patients randomized into the intervention will be assigned a lay health worker who will contact the patient to begin the intervention. The intervention includes: education on early advance care planning, documenting goals of care, assessing symptoms, and coordinating community services (such as home health, home visits, and home hospice).

The intervention arm will also receive usual care as provided by Unite Here Health and their local oncologists.

Behavioral: Lay Health Worker Intervention
Patients randomized into the intervention will be assigned a lay health worker who will contact the patient to begin the intervention. The intervention includes: education on early advance care planning, documenting goals of care, assessing symptoms, and coordinating community services (such as home health, home visits, and home hospice). The intervention is provided along with usual care as provided by Unite Here Health and local oncologists.

Other: Usual Care
Usual care as provided by Unite Here Health and local oncologists

Active Comparator: Control Group Arm
The control group arm will receive usual care as provided by Unite Here Health and their local oncologists.
Other: Usual Care
Usual care as provided by Unite Here Health and local oncologists




Primary Outcome Measures :
  1. Change in Patient Quality of Life Using the Functional Assessment of Cancer Therapy - General Survey [ Time Frame: Change in Quality of Life from baseline to 6 months. ] [ Time Frame: 4 months after patient enrollment ]
    Each patient will receive a quality of life survey (Functional Assessment of Cancer Therapy - General Survey) at baseline and 4 months. We will measure the change in quality of life at baseline to 4 months. Scores for quality of life will be assessed using the Functional Assessment of Cancer Therapy - General Survey-General survey.


Secondary Outcome Measures :
  1. Patient Satisfaction With Decision-Making Using the Satisfaction With Decision Survey [ Time Frame: 4 months after patient enrollment ]
    Each patient will receive a validated satisfaction with decision-making survey (The Satisfaction with Decision Survey) at 4 months after study enrollment.Satisfaction with Decision was assessed with the use of the 6-question Satisfaction with Decision Scale, on which scores range from 0 to 5, with higher scores indicating better satisfaction with decision-making. Scores for each group are averaged at 4 months after study enrollment.

  2. Patient activation using the Patient Activation Measure survey [ Time Frame: 4 months after patient enrollment ]
    Each patient will receive a validated patient activation survey using the Patient Activation Measure at 4 months after study enrollment. Responses are: disagree strongly, disagree, agree, agree strongly with higher activation correlated with responses of agree and agree strongly. Scores for each group will be averaged at 4 months after study enrollment.

  3. Patient activation using the Patient Activation Measure survey [ Time Frame: 12 months after study enrollment ]
    Each patient will receive a validated patient activation survey using the Patient Activation Measure at 12 months after study enrollment. Responses are: disagree strongly, disagree, agree, agree strongly with higher activation correlated with responses of agree and agree strongly. Scores for each group will be averaged 12 months after study enrollment.

  4. Emergency Department Visit (Chart Review) [ Time Frame: 4 months after patient enrollment ]
    Emergency Department Use for each patient will be abstracted by electronic medical record chart review for each patient at 4 months after enrollment.

  5. Emergency Department Visit (Chart Review) [ Time Frame: 12 months after patient enrollment ]
    Emergency Department Use for each patient will be abstracted by electronic medical record chart review for each patient at 12 months after enrollment.

  6. Hospitalization Visit (Chart Review) [ Time Frame: 4 months after patient enrollment ]
    Hospitalization use for each patient will be abstracted by electronic medical record chart review for each patient at 4 months after enrollment.

  7. Hospitalization Visits (Chart Review) [ Time Frame: 12 months after study enrollment ]
    Hospitalization use for each patient will be abstracted by electronic medical record chart review for each patient at 12 months after enrollment.

  8. Advance Directive Documentation (Chart Review) [ Time Frame: 4 months after patient enrollment ]
    Advance Directive documentation for each patient will be abstracted by electronic medical record chart review for each patient at 4 months after enrollment.

  9. Advance Directive Documentation (Chart Review) [ Time Frame: 12 months after patient enrollment ]
    Advance Directive documentation for each patient will be abstracted by electronic medical record chart review for each patient at 12 months after enrollment.

  10. Goals of Care Documentation (Chart Review) [ Time Frame: 4 months after patient enrollment ]
    Goals of Care documentation for each patient will be abstracted by electronic medical record chart review for each patient at 4 months after enrollment.

  11. Goals of Care Documentation (Chart Review) [ Time Frame: 12 months after patient enrollment ]
    Goals of Care documentation for each patient will be abstracted by electronic medical record chart review for each patient at 12 months after enrollment.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Newly diagnosed patients with a cancer diagnosis.
  2. Patients with any relapse or progressive disease (any cancer diagnosis) as identified by imaging or biopsy and confirmed by physician.
  3. The patients must be 18 years or older.
  4. Patients must have the capacity to verbally consent.

Exclusion Criteria:

Inability to consent to the study due to lack of capacity as documented by the referring physician.

Patients without a newly diagnosed malignancy or patients without relapse of disease.


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03699748


Contacts
Layout table for location contacts
Contact: Manali I Patel, MD MPH MS 650-723-4000 manalip@stanford.edu

Locations
Layout table for location information
United States, California
Stanford University School of Medicine Recruiting
Stanford, California, United States, 94305
Contact: Manali I Patel, MD MPH MS         
Principal Investigator: Manali I Patel, MD MPH MS         
Sponsors and Collaborators
Stanford University
National Institutes of Health (NIH)
National Institute on Minority Health and Health Disparities (NIMHD)
Investigators
Layout table for investigator information
Principal Investigator: Manali I Patel, MD MPH MS Stanford University

Layout table for additonal information
Responsible Party: Manali Indravadan Patel, Assistant Professor, Stanford University
ClinicalTrials.gov Identifier: NCT03699748     History of Changes
Other Study ID Numbers: 40447
K23MD013474-01 ( U.S. NIH Grant/Contract )
First Posted: October 8, 2018    Key Record Dates
Last Update Posted: October 1, 2019
Last Verified: September 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Manali Indravadan Patel, Stanford University:
cancer
end of life
patient-centered